Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2015, Annals of clinical biochemistry
A practice hypothyroid register is part of the quality and outcomes framework. In literature, the prevalence of hypothyroidism is stated to be 2% but the prevalence, defined from quality and outcomes framework data, is 3.2% in the UK and 3.6% in Plymouth. We sought to investigate the diagnosis of hypothyroidism and reasons for prescription of thyroxine to patients on the hypothyroid register in Plymouth. A letter was sent to the 10 practices with the highest prevalence of hypothyroidism requesting a list of patients on their registers. The hospital pathology system was used to identify those with biochemically documented hypothyroidism (defined as thyroid stimulating hormone >10mU/L) For two large practices the clinical records of the remaining patients were reviewed to ascertain the reasons for prescription of thyroxine and whether it led to symptomatic improvement. Seven practices responded with 1246 patients on their registers, of whom 43.6% had documented hypothyroidism. A re...
Indian Journal of Endocrinology and Metabolism
Are patients with primary hypothyroidism in India receiving appropriate thyroxine replacement? An observational study2014 •
Journal of primary health care
The reality of subclinical hypothyroidism in general practice2009 •
Subclinical hypothyroidism (SCH) is common, reported to affect 4-10% of the adult population. Recommendations for treatment of SCH are contentious, with protagonists even disagreeing over the rationale for medical intervention. How general practitioners (GPs) manage patients with elevated thyroid stimulating hormone (TSH) and normal thyroid hormone results are unknown. This study aimed to explore how GPs think about diagnosing and managing SCH. A qualitative study using focus groups conducted between December 2007 and March 2008 to understand how GPs perceive SCH and their diagnostic and management process. Thirteen GPs in three focus groups in Waikato, New Zealand participated. There is wide variability in how GPs perceive SCH and their knowledge of the disease. A patient-centred approach to diagnosis and management was commonly reported. Consideration of overt pathology and medicolegal issues also influenced perceptions of SCH, but lack of evidence regarding outcomes of treatment ...
BMC Endocrine Disorders
Time for a reassessment of the treatment of hypothyroidismInternational Journal of Advances in Medicine
A clinico-epidemiological analysis of subclinical hypothyroidism in a tertiary care health center2019 •
Background: Subclinical hypothyroidism (SCH) is defined by increase in serum thyroid stimulating hormone (TSH) and free thyroxine (FT4) and free triiodothyronine (FT3) levels within normal range, coupled with absence of typical clinical symptoms. The present study was undertaken to analyse the SCH associated comorbidities, especially lipid disturbances, thyroid autoantibodies, etc.Methods: The present study was retrospective observational study, which was carried out at a tertiary health care center.Results: Out of the 100 patients, majority were in the age group 21 to 30 years (31 patients), followed by 26 patients in age group >51 years and least in age group 41 to 50 years. Prevalence showed female predilection, with female: male ratio of 1.9:1. Most common symptom reported was general fatigue, which was encountered in 40 patients, followed by weight gain, menstrual abnormalities, and constipation. 10 patients were asymptomatic. Serum TSH range in the patients was 5 to 21.1 µI...
Vojnosanitetski pregled
Evaluation of a three-month trial of thyroxine replacement in symptomatic subclinical hypothyroidism: An impact on clinical presentation, quality of life and adoption of long-term therapy2020 •
Background/Aim. Although subclinical hypothyroidism (SCH) is frequently a biochemical diagnosis, some symptoms and signs of overt disease may be present, influencing our decision to start the treatment with levothyroxine (LT4). The aim of this study was to examine the effect a 3- month LT4 treatment on clinical presentation and quality of life in symptomatic SCH with thyroid-stimulating hormone (TSH) < 10 mIU/L. We also considered whether treatment discontinuation additionally improves reliability of these findings. Methods. Clinical parameters (disease-specific score) and quality of life (Short Form-36 questionnaire) were measured in 35 patients with persistent symptomatic SCH (TSH 7.0 ? 2.1 mIU/L) before the intervention (LT4 substitution), 3 months after the euthyroid state had been achieved and 3 months after cessation of LT4 substitution. Results. The median of the Zulewski index significantly decreased after the treatment with LT4: 5.0 (4.0?7.0) vs. 3.0 (2.0?5.0) (p < 0....
Drugs in Context
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited optionsLevothyroxine (LT4) therapy has a long history, a well-defined pharmacological profile and a favourable safety record in the alleviation of hypothyroidism. However, questions remain in defining the threshold for the requirement of treatment in patients with subclinical hypothyroidism, assessing the dose adequacy of the drug, and selecting the best treatment mode (LT4 monotherapy versus liothyronine [LT3]/LT4 combinations) for subpopulations with persisting complaints. Supplied as a prodrug, LT4 is enzymatically converted into the biologically more active thyroid hormone, triiodothyronine (T3). Importantly, tetraiodothyronine (T4) to T3 conversion efficiency may be impaired in patients receiving LT4, resulting in a loss of thyroid-stimulating hormone (TSH)-mediated feed-forward control of T3, alteration of the interlocking equilibria between serum concentrations of TSH, free thyroxine (FT4), and free triiodothyonine (FT3), and a decrease in FT3 to FT4 ratios. This downgrades the value of the TSH reference system derived in thyroid health for guiding the replacement dose in the treatment situation. Individualised conditionally defined setpoints may therefore provide appropriate biochemical targets to be clinically tested, together with a stronger focus on clinical presentation and future endpoint markers of tissue thyroid state. This cautionary note encompasses the use of aggregated statistical data from clinical trials which are not safely applicable to the individual level of patient care under these circumstances.
1999 •
With the aim of establishing optimal dosage schedules, 171 women with either overt (OH, n = 80) or subclinical (SCH, n = 91) hypothyroidism were assessed before and 6 months after starting L-thyroxine (LT4) replacement therapy. Each group was further classified into four subgroups according to post-therapy serum TSH level, as follows: A) complete suppression; B) partial suppression; C) normal range and D) above normal range (insufficient response). In all subgroups, LT4 doses were higher for OH than for SCH, whether expressed as total daily dose (micrograms) or as a function of either actual or ideal body weight (micrograms/kg BW). In OH, LT4 dose was higher for subgroups A or B as compared with either C or D. In SCH, subgroup A received a larger dose than the other subgroups. Post-treatment serum thyroxine levels showed the same pattern for both OH and SCH. Mean LT4 dose was similar in patients with high and normal antithyroid antibodies and in patients with goiter and in those wit...
Constructing the diagnosis - Hypothyroidism in the general practice
Constructing the diagnosis - Hypothyroidism in the general practice - DissertationWhat happens in the consultation room of the General Practice when a patient presents to a General Practitioner with a-typical symptoms? In this paper both the view of the general practioner and patient are the object of study. The contemplations and considerations of general practitioners are investigated, and the route described by patients towards the diagnosis hypothyroidism.
Endocrinology & Metabolic Syndrome
A Hospital-based Study for Clinico-investigative Profile of Newly Diagnosed Patients of HypothyroidismIntroduction: Hypothyroidism in adults has an insidious onset with a range of non-specific symptoms resulting in delayed diagnosis. Hypothyroidism is characterized by a broad clinical spectrum ranging from an overt state of myxedema, end-organ effects and multisystem failure to an asymptomatic or subclinical condition with normal levels of thyroxine and triiodothyronine and mildly elevated levels of serum thyrotropin. Thyroid dysfunction leads to altered glucose and lipid metabolism leading to insulin resistance, which is an important risk factor for cardio vascular diseases. This study attempts to study clinical and biochemical profile of patients with subclinical hypothyroidism or overt hypothyroidism.
Journal of Communications and Networks
Coverage protocols for wireless sensor networks: Review and future directions2019 •
2006 •
2018 •
2007 •
International Journal of Advanced Computer Science and Applications
An Improved Biometric Fusion System of Fingerprint and Face using Whale Optimization2021 •
IEEE Transactions on Energy Conversion
Detection of Artificial Insulation Defects in a Medium-Voltage Motor by Dielectric Spectroscopy Analysis2012 •
Atrio Revista De Historia Del Arte
Conectando con tierras onubenses: Fregenal de la Sierra (Badajoz) y su arquitectura rural2012 •
2012 •
Boletín de la Sociedad Geológica Mexicana
Abies cuitlahuacii sp. nov. a mummified Late Quaternary fossil wood from Chalco, Mexico2019 •
2021 •
2019 •
Kafkas Universitesi Veteriner Fakultesi Dergisi
Pakistan’ın Kuzey Pencab Bölgesinde Hypodermosis`in (Hypoderma sp.) Coğrafi Dağılımı2009 •
2009 •
Revista Científica Pakamuros
Efecto de la temperatura, tiempo y concentración de enzima comercial (Viscozyme L.) sobre el rendimiento de extracción de aceite de semillas de girasol (Helianthus annuus L.)2013 •
2015 •
Annals of Family Medicine
Antibiotic Prescribing for Acute Respiratory Tract Infections 12 Months After Communication and CRP Training: A Randomized Trial2019 •
Srpski arhiv za celokupno lekarstvo
Dexasone and metoclopramide vs. granisetron in the prevention of postoperative nausea and vomiting2019 •
2022 •